To The Moon

$Eli Lilly(LLY)$

$1,022 Pulls Back Slightly After Record High: GLP-1 Price Strategy Gains Traction, Eyes Breakout Toward $1,050》

Latest Close (EST):

LLY closed at $1,021.70 (-0.35%), down $3.58 from previous high of $1,025.28, just 1.2% away from the 52-week high of $1,033.62, maintaining strong upward momentum near record levels.

Core Market Drivers:

Trump's GLP-1 drug pricing agreement with Lilly sets monthly Medicare price at $245, unlocking 40+ million new patients despite price cuts;

Lilly's experimental weight-loss drug eloralintide showed 9.5%-20.1% weight reduction in Phase 2 trials, accelerating pipeline development.

Technical Analysis:

Trading volume at 4.72M shares with 1.02 volume ratio shows sustained institutional interest; current P/E of 49.98x remains elevated vs S&P 500's ~22x but justified by growth trajectory; recent consolidation above $1,000 psychological level indicates strong support formation.

Key Price Levels:

• Primary Support Zone: $998-1,000 — Daily low and psychological anchor; break below may trigger pullback to $980-985

• Resistance Cluster: $1,030-1,035 — 52-week high congestion area; breakthrough opens path to $1,050-1,070

• Pivot Point: $1,020 — Current price equilibrium maintaining bullish structure

Valuation Perspective:

Forward P/E of 43.21x significantly above historical average of 52.74x, reflecting market confidence in GLP-1 expansion and pipeline strength despite premium valuation.

Analyst Price Targets:

29 institutions maintain average target of $1,000.89, with range from $706-$1,500; recent upgrades include Citi's $1,500 target citing Orforglipron's $40B+ peak sales potential.

Week Ahead Outlook:

Expect continued consolidation in $1,000-1,035 range as market digests pricing strategy impacts; strong fundamentals support breakout above $1,035 targeting $1,050-1,070; downside limited to $980 support zone.

Risk Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice. Stock performance remains subject to regulatory changes, competitive dynamics, and broader market conditions. Invest cautiously.

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD 5000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.

Click to access the activity

Other helpful links:

• 💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉

• How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.